Navigation path

Evaluation of EU Regulations 469/2009 and 1610/96 on supplementary protection certificates for medicinal and plant protection products
Stakeholder event on Biosimilar medicinal products 30-10-2019 FINAL AGENDA
Summary report - Multi-stakeholder Workshop on Biosimilar Medicinal Products
Study on the economic impact of supplementary protection certificates, pharmaceutical incentives and rewards in Europe
Study on the legal aspects of Supplementary Protection Certificates in the EU
Questions and answers for patients - Biosimilar medicines explained
Multi-stakeholder Workshop on Biosimilar Medicinal Products
Presentations at the 2017 Stakeholder Workshop on Biosimilar Medicines
EC Stakeholder Workshop on Biosimilars 5 May 2017 final draft agenda
Report of the Multi-stakeholder Workshop on Biosimilar Medicinal Products, Brussels 20 June 2016
IMS Impact of Biosimilar Competition 2016
EC workshop on Biosimilars - Presentations
Agenda of the Multi-stakeholder Workshop on Biosimilar Medicinal Products, Brussels 20 June 2016
IMS Report - The Impact of Biosimilar Competition
What I need to know about Biosimilar Medicines - Information for patients
IMS Reading Guide Impact of Biosimilar Competition 2015
IMS Observations Impact of Biosimilar Competition 2015
IMS Impact of Biosimilar Competition 2015
Report - EC Multi-stakeholder Workshop - Biosimilars - 6 October 2015
EC workshop on biosimilars 6_10_15 concept and agenda
EC workshop on biosimilars - Presentations
EU-Africa Pharma Business to Business Forum: An exchange of views between regulators and business community from Europe and Africa (16/09/2013)
Terms of reference (Platform on Ethics & Transparency)
Priority Medicines for Europe and the World (Update Report 2013)
Report (Platform on access to medicines in Europe - Working group on Promoting a good governance for non-prescription drugs)
Results per page: 5 10 15 20 25 | Page 1 out of 3

Additional tools